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*+ Dihydropyridine-sensitive Ca channels and the relationship between binding of dihydropyridine d rivatives and depo- 
larization-induced Ca*+ uptake have been studied in aneurally cultured human muscle. Analysis of the equilibrium bind- 
ing of the 1,4-dihydropyridine derivative (+)-PN200-110 revealed a single high-affinity binding site with a E(d of 
0.15f0.05 nM and a B,., of 87 k 12 fmol/mg protein. Inhibition of (+)-PH]PNZOO-1 10 binding by nitrendipine revealed 
a Ki of 0.8 nM for the nitrendipine-receptor complex. Depolarization of cultured human muscle achieved by elevating 
the K+ concentration increased the uptake %a*” which was inhibited by nitrendipine with an IC,, of 1.1 nM. This study 
demonstrates that aneurally cultured human muscle has dihydropyridine-sensitive oltage-dependent CaZf channels 
which are functional when the fibers are depolarized. 
Ca*+ channel; Dihydropyridine receptor; Muscle culture 
1. INTRODUCTION 
Dihydropyridine derivatives such as nitrendipine 
or PN200-110, a subgroup of Ca2+ antagonists, 
have been widely used to identify and characterize 
Ca’+ channels in several tissues. They are known 
to bind to one class of voltage-activated Ca2+ 
channels in the cell membrane [ 11. Voltage- 
dependent Ca2+ channels and 1 ,bdihydropyridine 
receptors are found in many tissues but skeletal 
muscle has the highest density [2]. 
Dihydropyridine receptors are present on the exter- 
nal membranes of adult human muscle 131. In 
animal skeletal muscle, voltage-dependent Ca2+ 
channels are assumed to be localized in the 
transverse-tubular membrane (t-tubules) [4,5]. 
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Developmental aspects of 1,6dihydropyridine 
receptors have been previously studied in em- 
bryonic chick and rat muscle developing both in 
tissue culture [6] and in vivo [7]. Biochemical 
studies of voltage-dependent Ca2+ channels in 
developing human muscle have not been reported. 
Since human fetal material is virtually unavailable 
for this kind of systematic developmental study, 
tissue culture of an adult human muscle provides 
the only suitable model for this kind of investiga- 
tion. Aneural tissue cultures of diseased adult 
human muscle have proved to be important as a 
tool for studying the pathogenesis of 
neuromuscular disorders [8], and tissue cultures of 
normal human muscle provided important infor- 
mation regarding various aspects of human muscle 
development [9, lo]. 
Here, we describe the properties of 
1,4-dihydropyridine-sensitive Ca2+ channels and 
the relationship between binding of 1,4-dihydro- 
pyridine derivatives and depolarization-induced 
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Ca2+ uptake in aneurally cultured normal human 
muscle. 
2. MATERIALS AND METHODS 
2. I. Cell cultures 
Cultures were estabiished from muscle biopsies of patients 
with no evidence of intrinsic muscle cell disorders after all 
diagnostic tests were performed. Muscle cultures were establish- 
ed according to our explant re-explantation technique [ 111. In 
brief about 7-10 days after explantation the original explants 
were removed and outgrowing cells were trypsinized, and plated 
in gelatin-coated 35mm petri dishes at a concentration of 1 x 
lo6 cells per dish. The cells were grown until fusion in a mixture 
of Dulbecco’s modified Eagle’s medium and medium 199 (Gib- 
co, Santa Clara, CA) (3: 1, v/v) supplemented with 10% fetal 
bovine serum (Hy-Clone, Logan, UT), insulin (Sigma, St. 
Louis, MO) (10 ag/ml), epidermal growth factor (Collaborative 
Research, Lexington, MA) (10 ng/ml) and fibroblast growth 
factor (25 ng/ml). Immediately after fusion (5-7 days after in- 
itiation of cultures) insulin and the growth factors were re- 
moved, and the cells continued to grow for 18-21 days in the 
medium supplemented only with 10% fetal bovine serum. 
Ca’+-uptake experiments and electrophysiologic studies were 
performed directly in the 35mm petri dishes. For binding ex- 
periments, cells were harvested and homogenized by sonication 
(Branson sonifier, set 6, 10 s) in Duibecco’s phosphate-buffered 
saline without Ca*+ and Mg+ (Gibco) (3-5 mg protein/ml) and 
the homogenates were stored at - 80°C until use. 
2.2. Dihydropyridine-binding assays 
Dihydropyridine-binding sites were assayed as in [3] using 
(+)-[methyl-‘H]PN200-110 (New England Nuclear, Boston, 
MA; 70-85 Ci/mmol). Cell homogenate aliquots (0.1-0.2 mg 
protein) were incubated for 1 h at 25°C in 1 ml of 50 mM Tris- 
Cl buffer, pH 7.4, containing 0.1 mM phenylmethylsulfonyl 
fluoride, in the presence of increasing concentrations of 
radioligand from 0.05 to 2 nM. At the end of incubation, 40021 
aliquots were filtered in duplicate under vacuum on Whatman 
glass-fiber filters @F/B) with extensive washing with 50 mM 
Tris-Cl buffer, pH 7.4. Radioactivity bound to filters was 
measured using Biofluor (New England Nuclear) in a Packard 
2660 scintillation spectrometer with dpm correction. 
Saturation-isotherm data were analyzed by a software package 
(Lundon Software, Cleveland, OH) that sequentially examines 
the experimental data for l- and 2-site binding models and 
statistically determines the best fit and most reliable estimates 
of binding parameters (standard errors of parameter estimates, 
sums of squares error of the fitted curve, ‘run test’ to detect he 
presence of non-randomness in the data and ‘F test to compare 
the goodness of fit between models). 
Competition-isotherm experiments between labeled ( + )- 
PN200-110 and unlabeled nitrendipine were performed on 
homogenate aliquots (0.1-0.2 mg protein) incubated under the 
same conditions as for saturation experiments. A fixed concen- 
tration of (+)-[‘H]PN200-110 (l-l.5 nM) and increasing con- 
centrations of nitrendipine (from 0.1 nM to 1 CM) were used. 
The ability of nitrendipine to inhibit specific (+)- 
[‘H]PN200-100 binding to its receptor was characterized by the 
ICrc value, i.e., the concentration of the compound which in- 
96 
hibits binding by 50% under the particular experimental condi- 
tions. The overall apparent dissociation constant Ki of the 
inhibition for (+)-[‘H]PN200-110 binding by nitrendipine and 
the Hill transformation were calculated as described [12]. 
2.3. CaZ’ -jlux experiments 
Ca*+-uptake studies were performed using the general prin- 
ciples described [6]. The amount of accumulated 4sCa2’ was 
determined in plated cells at 37°C in 25 mM Hepes-Tris buffer 
(pH 7.3) containing 5 mM glucose (buffer 1) supplemented with 
1.8 mM CaClr, 3 &i/ml 45Ca2+ (NEN). Experiments were con- 
ducted in either high KC (40 mM KCl-105 mM NaCl; depola- 
rized condition) or low K+ concentration (5 mM KC]-140 mM 
NaCl; polarized condition). Time course experiments were per- 
formed at 37°C as follows: (i) cultures were preincubated for 
15 min in buffer I containing either high or low K+; (ii) 45Ca2+ 
uptake was measured on cells maintained in the corresponding 
incubation media (40 or 5 mM Kf), supplemented with cold 
and labeled Ca*+, in the absence or presence of 2 PM nitren- 
dipine. The time course of 45Ca2+ uptake was studied by remov- 
ing the medium by aspiration at different time intervals between 
0 and 4 min. Dose-response curves for nitrendipine inhibition 
of 45Ca2+ uptake were also determined after a 15-min prein- 
cubation in buffer 1 but containing high K+ concentration, us- 
ing a fixed incubation time (30 s) and in the presence of 
increasing concentrations of nitrendipine from 0.1 nM to 
10pM. In both cases, for time course and dose-response x- 
periments, at the end of incubation, cells were washed three 
times with 2 ml buffer 1 containing 140 mM choline-chloride 
and 1 mM La”+. After the third wash 2 ml of 0.1 N NaOH was 
added to each dish and left for 2 h. The radioactivity incor- 
porated by the cells was counted in Aquassure (NEN) in a scin- 
tillation spectrometer with dpm correction. All measurements 
were done in duplicates. 
All experiments using dihydropyridine derivatives were per- 
formed in subdued lighting because of the light sensitivity of 
these compounds. Protein determinations were performed ac- 
cording to [13]. 
2.4. Electrophysiology 
Electrophysiologic studies were conducted (Dr T. Kobayashi) 
on cultured human muscle as in [14]. 18-21-day-old myotubes 
from different culture sets (n = 10) were studied at 35°C using 
an inverted microscope and microelectrodes filled with 3 M KC1 
and having a resistance of between 15 and 20 Mda for in- 
tracellular recording. Permanent record of the resting mem- 
brane potential (RMP) was monitored after commencing 
incubation of the culture under the condition defined as low K+ 
concentration (5 mM) for uptake experiments. K+ concentra- 
tion was then progressively increased to 40 mM by infusion of 
the culture dish. After RMP plateaued, washout with low K+ 
concentration medium was checked for reversion to the 
baseline. 
3. RESULTS 
3.1. Dihydropyridine receptor in cultured human 
muscles 
The results of the equilibrium saturation assay 
experiments of ( + )-[3H]PN200-1 0 in cultured 
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human muscle are presented in fig.1. Computer 
analysis of the data revealed one population of 
saturable high-affinity binding sites in the range of 
the radioligand used with a dissociation constant 
(Kd) of 0.15 _+ 0.05 nM and a maximal number of 
binding sites (Bmax) of 87 _+ 12 fmol/mg protein 
(average of 6 separate determinations, from 
cultured muscle homogenates, each from a dif- 
ferent patient biopsy). 
Inhibition of (+)-[3H]PN200-110 binding by 
nitrendipine in human muscle cultures is shown in 
fig.2. In typical experiments, using 0.5-1 nM ( + )- 
[3HIPN200-110, non-specific binding, defined as 
binding in the presence of 2/zM nitrendipine, was 
approx. 50% of total binding. The inhibition of 
binding appeared monophasic with a Hill slope 
slightly less than 1.0, indicating that (+)- 
[3H]PN200-110 binding to its muscle receptor was 
competitively inhibited by nitrendipine. The data 
obtained from two different experiments with two 
different culture sets gave a concentration for half- 
maximal inhibition by nitrendipine of (+)- 
[3H]PN200-110 binding (IC5o) of 5.2 nM. The Ki 
for the nitrendipine-receptor c mplex calculated 
from the IC5o value was 0.8 nM, similar to the Kd 
values obtained in adult human muscle 
homogenate using tritiated nitrendipine [15] and 
cultured embryonic chick muscle [6] (0.5 and 
0.4 nM, respectively). 
3.2. Nitrendipine-sensitive 45Ca3+ uptake in 
cultured human muscle 
The influence of nitrendipine on 45Ca2+ uptake 
in cultured human muscle was analyzed in high 
and low K + buffers. An increase in K + concentra- 
tion in the incubation buffer from 5 to 40 mM 
resulted in increasing accumulation of 45Ca2+ in 
cultured human muscle cells (fig.3) caused by 
depolarization f the muscle fibers by the high K + 
concentration. In our cultured human muscle 
membrane potential changed from -53 + 6 to 
- 26 + 4 mV when the K + concentration rose from 
5 to 40mM. K+-stimulated, time-dependent, 
45Ca2+ uptake was rapid, being half-maximal 
within 30 s. The initial rate of 45Ca2+ accumula- 
tion in 40 mM K + was approx. 4-times that 
measured in 5 mM K +. Extrapolated from the in- 
itial rates of uptake, more than 1 nmo145CaZ+/min 
per mg protein could be transported under the high 
K + condition vs only 0.3 nmol/min per mg protein 
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Fig. 1. Typical example of binding of ( + )- 
[methyl)H]PN200-110 to human cultured muscle 
homogenates. Experiment was carried out as described in 
section 2. Protein concentration was 0.13 mg/ml. (Inset) Total 
(Br) (+)-[3H]PN200-110 binding (o) was fitted by the 
computerized analysis with a non-linear model. Non-specific 
binding (BNs) and specific binding (Bs), reported as broken 
lines, were calculated from the total binding data. The main 
figure shows a Scatchard representation from the saturation 
isotherm data for total binding (Br). The saturable specific 
binding (Bs) was calculated after subtraction of the non- 
saturable binding (BNs) participating. In this typical experiment 
Kd = 0.165 nM and Bmu = 82 fmol/mg protein. 
in the case of the low K ÷ condition. K+-stimulated 
45Ca2÷ uptake plateaued in approx. 2 min, after 
which the rate of 45Ca2+ accumulation i 40 mM 
K ÷ paralleled the rate observed in 5 mM K ÷. The 
depolarization-induced 45Ca2÷ uptake was not 
dependent upon extracellular Na ÷ concentration 
and thus was not due to Na+/Ca 2÷ exchange, since 
uptake could be demonstrated when NaC1 was 
replaced by choline in the incubation buffer. The 
t ime-dependent  45Ca2+ uptake induced by K + was 
inhibited by 2/~M nitrendipine (fig.3). The dose- 
response curve for the effect of nitrendipine on 
45Ca2+ uptake is shown in the inset to fig.3. When 
cells were incubated under depolarizing conditions 
for 30 s with increasing concentrations of nitren- 
dipine, the nitrendipine-sensitive rates of 4SCa2+ 
uptake were obtained by subtracting from the in- 
itial rates of 45Ca2+ uptake the values obtained 
under the same conditions in the presence of 2/zM 
nitrendipine. The concentration for half-maximal 
inhibition of the 45Ca2÷ uptake was 1.1 nM (two 
97 
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Fig.2. Inhibition of specific (+)-[methyl-3H]PN200-110 
(76 Ci/mmol) binding in human cultured muscle homogenate 
by increasing concentrations of unlabeled nitrendipine 
measured under equilibrium conditions at 25°C and expressed 
as percent of maximum specific binding (100% = absence of 
nitrendipine). In this typical example, using 1.2 nM (+)- 
[‘H]PN200-110, half displacement was observed at 5.1 nM. 
Determined in parallel on the same preparation by direct 
binding Kd was 0.20 nM. Data in the text are means from two 
different culture sets, each assay in duplicate. 
1 2 3 4 
Time (minute) 
Fig.3. Ca*+ flux experiments. Time course of %a’+ 
accumulation into human muscle in culture. Uptake of %a’+ 
in buffer containing 40 mM K+ (o), 5 mM K+ (0) and 40 mM 
K+ in the presence of 2pM nitrendipine (A) were determined 
for the incubation times indicated as described in section 2. 
(Inset) Inhibition of specific nitrendipine-sensitive 45Ca2+ flux 
in high K+ medium. Values indicated are expressed as percent 
of control of K+-stimulated uptake for incubation in high K+ 
medium in the absence of nitrendipine. Specific nitrendipine- 
sensitive ‘%Za2+ accumulation was defined as the uptake 
obtained in the presence of 2cM nitrendipine. Data are 
averages of two separate experiments from different sets of 
culture each conducted in duplicate. 
experiments in duplicate from two different sets of 
muscle cultures). 
4. DISCUSSION 
The present findings in aneural human muscle 
cultures include demonstration of: (i) a high- 
affinity binding site for 1,6dihydropyridine 
derivatives, (ii) K+ depolarization-induced 4’CaZ+ 
uptake and (iii) a correlation between the binding 
affinity of the 1,4-dihydropyridine-receptor com- 
plex and direct inhibition by 1 ,Cdihydropyridine 
of 45Ca2+ uptake under depolarizing condition. 
We found that (+)-PN200-110 binds to a 
specific and saturable high-affinity site (& 
0.15 nM) in cultured human skeletal muscle. This 
binding was competitively inhibited by nanomolar 
nitrendipine, indicating that nitrendipine binds 
with high affinity to this receptor (Ki 0.8 nM). 
Similar high-affinity binding was found for (+)- 
[3H]PN200-1 0 and [3H]nitrendipine binding to 
the 1 ,Cdihydropyridine receptor of surface mem- 
branes isolated from adult human skeletal muscle 
[3] and in crude homogenates from adult human 
muscle [14] (0.2 and 0.5 nM, respectively). In con- 
trast with adult muscle, the 1,6dihydropyridine 
receptor concentration in aneurally cultured 
human muscle is low (87 fmol/mg protein in 
culture vs 460 fmol/mg protein to 7 pmol/mg pro- 
tein in adult human muscle depending on the 
degree of purification of membranes) (cf. [3,15]). 
Biochemical and electrophysiologic data have 
shown that in adult animal muscle voltage- 
dependent Ca2+ channels are mainly localized in 
the transverse tubular system [16,17]. Since 
cultured human muscle fiber grown aneurally 
under the present conditions do not have well 
organized t-tubules, the localization of the 
1,6dihydropyridine receptor in this cultured mus- 
cle remains obscure. One possible explanation is 
that an unorganized primitive tubular system ex- 
isting in aneurally cultured muscle (presumably 
pre-t-tubule structures) contains voltage- 
dependent Ca2+ channels. However, the possible 
existence of voltage-dependent Ca2+ channels in 
other structures cannot be ruled out. 
Electrophysiologic studies of human muscle 
cultured for 8-15 days by others under different 
conditions failed to demonstrate Ca2+ conductance 
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[ 181, suggesting the absence of a voltage-dependent 
Ca2+ channel in this cell. Whether this obvious dif- 
ference between their studies and ours reflects the 
difference in sensitivity between electrophy- 
siological and biochemical analysis of voltage- 
dependent Ca ‘+ channels or a different stage of 
maturation of human muscle cultured under dif- 
ferent conditions cannot be answered as yet. 
In the present study, in aneurally cultured mus- 
cle the Ca2+ channel function is analyzed in terms 
of depolarization-induced Ca2+ uptake. De- 
polarization of muscle culture by high K+ induces 
a greater 45Ca2+ flux than under polarized condi- 
tions in low K+. This depolarization-induced Ca2+ 
flux is almost completely eliminated in the 
presence of 2/1M nitrendipine. Similar observa- 
tions have been made with a clonal 
pheochromocytoma cell line (PC 12) in culture 
[ 19,201, primary cultures of cerebellar granule cells 
[21] and primary cultures of chick embryo muscle 
[6]. When compared with those tissues, the time 
course of accumulation of 45Ca2+ in primary 
cultures of human muscle is longer and the ability 
to accumulate Ca2+ 5-20-times lower. The low 
concentration of voltage-dependent Ca2+ channels 
in this system demonstrated by binding studies 
could explain such observations. 
In intact frog sartorius muscle the affinity con- 
stant for the complex formed by l,Cdihydro- 
pyridine with its receptor was found to be lOO- 
times lower than the half-maximal concentration 
of 1,Cdihydropyridine needed to block muscle 
contraction in this particular preparation [22]. 
Therefore, it was postulated that the l,Cdihydro- 
pyridine receptor in muscle was not the functional 
Ca2+ channel. Our biochemical and pharmaco- 
kinetic studies of cultured human muscle demon- 
strate that (i) 1 ,Cdihydropyridine derivatives bind 
to a single class of saturable high-affinity sites in 
cell homogenates and (ii) half-maximal blockade 
by nitrendipine of 45Ca2+ flux measured in high K+ 
concentration on intact cells is in a similar nano- 
molar range. These findings suggest that under 
depolarized conditions, inhibition of 45Ca2+ up- 
take by 1 ,Cdihydropyridine may be functionally 
linked to this high-affinity dihydropyridine- 
binding site. These results are in agreement with 
electrophysiological studies in animal cardiac [23] 
and skeletal muscle [24] which demonstrated that 
the high-affinity 1,4-dihydropyridine-binding site 
and the inactivated muscle voltage-dependent Ca” 
channel were identical. 
In conclusion, the close relationship between the 
biochemically determined and the functional 
properties of the dihydropyridine-receptor com- 
plex has been demonstrated in aneurally cultured 
human skeletal muscle using 1 ,Qdihydropyridine 
binding and Ca2+-flux techniques. These data, in 
agreement with the previously described role of the 
1,Cdihydropyridine receptor, may serve as a basis 
for studying voltage-dependent Ca2+ channels in 
cultured human muscle from patients with 
neuromuscular diseases in which membrane abnor- 
mality is suspected. Further biochemical studies of 
voltage-dependent Ca2+ channels in our new 
culture system, in which human muscle cultured in 
monolayers is functionally innervated by fetal rat 
spinal cord and has well developed t-tubules 
[25,26], will be of importance in evaluating the in- 
fluence of neural factors on the developmental 
properties of voltage-dependent Ca2+ channels. 
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